DIFLORASONE DIACETATE Recall D-0681-2022
Description: Diflorasone Diacetate Ointment USP, 0.05%, Net Wt 60 g tubes, Rx only, Manufactured for: SOLA Pharmaceuticals, LLC Baton Rouge, LA 70809, NDC 70512-031-60.
DIFLORASONE DIACETATE Recall D-0681-2022 Information
Status | Ongoing |
Mandated? | Voluntary: Firm initiated |
Recall Number | D-0681-2022 |
Event ID | 89798 |
Brand | DIFLORASONE DIACETATE OINT |
Generic Name | DIFLORASONE DIACETATE OINTMENT |
Manufacturer | DIFLORASONE DIACETATE OINTMENT |
Original Package? | 1 |
Active Substance | DIFLORASONE DIACETATE |
Drug Route | TOPICAL |
Distribution | Nationwide in the USA and Puerto Rico |
Quantity | 24,304 bottles |
Recall Reason | cGMP deviations: all products within expiry are being recalled because the firm is discontinuing its stability study program. |
Drug Classification | Class II |
Drug Code Info | 20220330 |
Product NDC | 70512-031 |
Drug UPC | 0370512031602 |
Recall Initiation Date | 20220315 |
Report Date | 20220330 |
Classification Date | 20220321 |
Address | 105 Lincoln Avenue Buena, NJ 08310 United States |
Recalling Firm | Teligent Pharma, Inc. |
Initial Notification | Letter |
Unique Ingredient Identifier | 7W2J09SCWX |
Drug Application Number | ANDA210753 |
Structured Product Labeling (SPL ID) | b8b8c0e8-fb69-048b-e053-2a95a90afbbb |
Structured Product Labeling (SPL Set ID) | 81a55188-1f73-c212-e053-2991aa0a0719 |
Similar To |